Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Systemic Infection Therapy Revenue 1.4 Market Analysis by Type 1.4.1 Global Systemic Infection Therapy Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Oral 1.4.3 Intravenous 1.4.4 Topical 1.5 Market by Application 1.5.1 Global Systemic Infection Therapy Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Systemic Infection Therapy Market Perspective (2015-2026) 2.2 Systemic Infection Therapy Growth Trends by Regions 2.2.1 Systemic Infection Therapy Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Systemic Infection Therapy Historic Market Share by Regions (2015-2020) 2.2.3 Systemic Infection Therapy Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Systemic Infection Therapy Market Growth Strategy 2.3.6 Primary Interviews with Key Systemic Infection Therapy Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Systemic Infection Therapy Players by Market Size 3.1.1 Global Top Systemic Infection Therapy Players by Revenue (2015-2020) 3.1.2 Global Systemic Infection Therapy Revenue Market Share by Players (2015-2020) 3.1.3 Global Systemic Infection Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Systemic Infection Therapy Market Concentration Ratio 3.2.1 Global Systemic Infection Therapy Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Systemic Infection Therapy Revenue in 2019 3.3 Systemic Infection Therapy Key Players Head office and Area Served 3.4 Key Players Systemic Infection Therapy Product Solution and Service 3.5 Date of Enter into Systemic Infection Therapy Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Systemic Infection Therapy Historic Market Size by Type (2015-2020) 4.2 Global Systemic Infection Therapy Forecasted Market Size by Type (2021-2026) 5 Systemic Infection Therapy Breakdown Data by Application (2015-2026) 5.1 Global Systemic Infection Therapy Market Size by Application (2015-2020) 5.2 Global Systemic Infection Therapy Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Systemic Infection Therapy Market Size (2015-2020) 6.2 Systemic Infection Therapy Key Players in North America (2019-2020) 6.3 North America Systemic Infection Therapy Market Size by Type (2015-2020) 6.4 North America Systemic Infection Therapy Market Size by Application (2015-2020) 7 Europe 7.1 Europe Systemic Infection Therapy Market Size (2015-2020) 7.2 Systemic Infection Therapy Key Players in Europe (2019-2020) 7.3 Europe Systemic Infection Therapy Market Size by Type (2015-2020) 7.4 Europe Systemic Infection Therapy Market Size by Application (2015-2020) 8 China 8.1 China Systemic Infection Therapy Market Size (2015-2020) 8.2 Systemic Infection Therapy Key Players in China (2019-2020) 8.3 China Systemic Infection Therapy Market Size by Type (2015-2020) 8.4 China Systemic Infection Therapy Market Size by Application (2015-2020) 9 Japan 9.1 Japan Systemic Infection Therapy Market Size (2015-2020) 9.2 Systemic Infection Therapy Key Players in Japan (2019-2020) 9.3 Japan Systemic Infection Therapy Market Size by Type (2015-2020) 9.4 Japan Systemic Infection Therapy Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Systemic Infection Therapy Market Size (2015-2020) 10.2 Systemic Infection Therapy Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Systemic Infection Therapy Market Size by Type (2015-2020) 10.4 Southeast Asia Systemic Infection Therapy Market Size by Application (2015-2020) 11 India 11.1 India Systemic Infection Therapy Market Size (2015-2020) 11.2 Systemic Infection Therapy Key Players in India (2019-2020) 11.3 India Systemic Infection Therapy Market Size by Type (2015-2020) 11.4 India Systemic Infection Therapy Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Systemic Infection Therapy Market Size (2015-2020) 12.2 Systemic Infection Therapy Key Players in Central & South America (2019-2020) 12.3 Central & South America Systemic Infection Therapy Market Size by Type (2015-2020) 12.4 Central & South America Systemic Infection Therapy Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Abbott Laboratories 13.1.1 Abbott Laboratories Company Details 13.1.2 Abbott Laboratories Business Overview and Its Total Revenue 13.1.3 Abbott Laboratories Systemic Infection Therapy Introduction 13.1.4 Abbott Laboratories Revenue in Systemic Infection Therapy Business (2015-2020)) 13.1.5 Abbott Laboratories Recent Development 13.2 Merck & Co. 13.2.1 Merck & Co. Company Details 13.2.2 Merck & Co. Business Overview and Its Total Revenue 13.2.3 Merck & Co. Systemic Infection Therapy Introduction 13.2.4 Merck & Co. Revenue in Systemic Infection Therapy Business (2015-2020) 13.2.5 Merck & Co. Recent Development 13.3 Pfizer 13.3.1 Pfizer Company Details 13.3.2 Pfizer Business Overview and Its Total Revenue 13.3.3 Pfizer Systemic Infection Therapy Introduction 13.3.4 Pfizer Revenue in Systemic Infection Therapy Business (2015-2020) 13.3.5 Pfizer Recent Development 13.4 GlaxoSmithKline 13.4.1 GlaxoSmithKline Company Details 13.4.2 GlaxoSmithKline Business Overview and Its Total Revenue 13.4.3 GlaxoSmithKline Systemic Infection Therapy Introduction 13.4.4 GlaxoSmithKline Revenue in Systemic Infection Therapy Business (2015-2020) 13.4.5 GlaxoSmithKline Recent Development 13.5 Novartis 13.5.1 Novartis Company Details 13.5.2 Novartis Business Overview and Its Total Revenue 13.5.3 Novartis Systemic Infection Therapy Introduction 13.5.4 Novartis Revenue in Systemic Infection Therapy Business (2015-2020) 13.5.5 Novartis Recent Development 13.6 Johnson & Johnson 13.6.1 Johnson & Johnson Company Details 13.6.2 Johnson & Johnson Business Overview and Its Total Revenue 13.6.3 Johnson & Johnson Systemic Infection Therapy Introduction 13.6.4 Johnson & Johnson Revenue in Systemic Infection Therapy Business (2015-2020) 13.6.5 Johnson & Johnson Recent Development 13.7 Sun Pharmaceuticals 13.7.1 Sun Pharmaceuticals Company Details 13.7.2 Sun Pharmaceuticals Business Overview and Its Total Revenue 13.7.3 Sun Pharmaceuticals Systemic Infection Therapy Introduction 13.7.4 Sun Pharmaceuticals Revenue in Systemic Infection Therapy Business (2015-2020) 13.7.5 Sun Pharmaceuticals Recent Development 13.8 Roche 13.8.1 Roche Company Details 13.8.2 Roche Business Overview and Its Total Revenue 13.8.3 Roche Systemic Infection Therapy Introduction 13.8.4 Roche Revenue in Systemic Infection Therapy Business (2015-2020) 13.8.5 Roche Recent Development 13.9 Astra Zeneca 13.9.1 Astra Zeneca Company Details 13.9.2 Astra Zeneca Business Overview and Its Total Revenue 13.9.3 Astra Zeneca Systemic Infection Therapy Introduction 13.9.4 Astra Zeneca Revenue in Systemic Infection Therapy Business (2015-2020) 13.9.5 Astra Zeneca Recent Development 13.10 Wockhardt 13.10.1 Wockhardt Company Details 13.10.2 Wockhardt Business Overview and Its Total Revenue 13.10.3 Wockhardt Systemic Infection Therapy Introduction 13.10.4 Wockhardt Revenue in Systemic Infection Therapy Business (2015-2020) 13.10.5 Wockhardt Recent Development 13.11 Mylan Pharma 10.11.1 Mylan Pharma Company Details 10.11.2 Mylan Pharma Business Overview and Its Total Revenue 10.11.3 Mylan Pharma Systemic Infection Therapy Introduction 10.11.4 Mylan Pharma Revenue in Systemic Infection Therapy Business (2015-2020) 10.11.5 Mylan Pharma Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Systemic Infection Therapy Key Market Segments Table 2. Key Players Covered: Ranking by Systemic Infection Therapy Revenue Table 3. Ranking of Global Top Systemic Infection Therapy Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Systemic Infection Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Oral Table 6. Key Players of Intravenous Table 7. Key Players of Topical Table 8. Global Systemic Infection Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Systemic Infection Therapy Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Systemic Infection Therapy Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Systemic Infection Therapy Market Share by Regions (2015-2020) Table 12. Global Systemic Infection Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Systemic Infection Therapy Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Systemic Infection Therapy Market Growth Strategy Table 18. Main Points Interviewed from Key Systemic Infection Therapy Players Table 19. Global Systemic Infection Therapy Revenue by Players (2015-2020) (Million US$) Table 20. Global Systemic Infection Therapy Market Share by Players (2015-2020) Table 21. Global Top Systemic Infection Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Systemic Infection Therapy as of 2019) Table 22. Global Systemic Infection Therapy by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Systemic Infection Therapy Product Solution and Service Table 25. Date of Enter into Systemic Infection Therapy Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Systemic Infection Therapy Market Size by Type (2015-2020) (Million US$) Table 28. Global Systemic Infection Therapy Market Size Share by Type (2015-2020) Table 29. Global Systemic Infection Therapy Revenue Market Share by Type (2021-2026) Table 30. Global Systemic Infection Therapy Market Size Share by Application (2015-2020) Table 31. Global Systemic Infection Therapy Market Size by Application (2015-2020) (Million US$) Table 32. Global Systemic Infection Therapy Market Size Share by Application (2021-2026) Table 33. North America Key Players Systemic Infection Therapy Revenue (2019-2020) (Million US$) Table 34. North America Key Players Systemic Infection Therapy Market Share (2019-2020) Table 35. North America Systemic Infection Therapy Market Size by Type (2015-2020) (Million US$) Table 36. North America Systemic Infection Therapy Market Share by Type (2015-2020) Table 37. North America Systemic Infection Therapy Market Size by Application (2015-2020) (Million US$) Table 38. North America Systemic Infection Therapy Market Share by Application (2015-2020) Table 39. Europe Key Players Systemic Infection Therapy Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Systemic Infection Therapy Market Share (2019-2020) Table 41. Europe Systemic Infection Therapy Market Size by Type (2015-2020) (Million US$) Table 42. Europe Systemic Infection Therapy Market Share by Type (2015-2020) Table 43. Europe Systemic Infection Therapy Market Size by Application (2015-2020) (Million US$) Table 44. Europe Systemic Infection Therapy Market Share by Application (2015-2020) Table 45. China Key Players Systemic Infection Therapy Revenue (2019-2020) (Million US$) Table 46. China Key Players Systemic Infection Therapy Market Share (2019-2020) Table 47. China Systemic Infection Therapy Market Size by Type (2015-2020) (Million US$) Table 48. China Systemic Infection Therapy Market Share by Type (2015-2020) Table 49. China Systemic Infection Therapy Market Size by Application (2015-2020) (Million US$) Table 50. China Systemic Infection Therapy Market Share by Application (2015-2020) Table 51. Japan Key Players Systemic Infection Therapy Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Systemic Infection Therapy Market Share (2019-2020) Table 53. Japan Systemic Infection Therapy Market Size by Type (2015-2020) (Million US$) Table 54. Japan Systemic Infection Therapy Market Share by Type (2015-2020) Table 55. Japan Systemic Infection Therapy Market Size by Application (2015-2020) (Million US$) Table 56. Japan Systemic Infection Therapy Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players Systemic Infection Therapy Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Systemic Infection Therapy Market Share (2019-2020) Table 59. Southeast Asia Systemic Infection Therapy Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia Systemic Infection Therapy Market Share by Type (2015-2020) Table 61. Southeast Asia Systemic Infection Therapy Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia Systemic Infection Therapy Market Share by Application (2015-2020) Table 63. India Key Players Systemic Infection Therapy Revenue (2019-2020) (Million US$) Table 64. India Key Players Systemic Infection Therapy Market Share (2019-2020) Table 65. India Systemic Infection Therapy Market Size by Type (2015-2020) (Million US$) Table 66. India Systemic Infection Therapy Market Share by Type (2015-2020) Table 67. India Systemic Infection Therapy Market Size by Application (2015-2020) (Million US$) Table 68. India Systemic Infection Therapy Market Share by Application (2015-2020) Table 69. Central & South America Key Players Systemic Infection Therapy Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Systemic Infection Therapy Market Share (2019-2020) Table 71. Central & South America Systemic Infection Therapy Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America Systemic Infection Therapy Market Share by Type (2015-2020) Table 73. Central & South America Systemic Infection Therapy Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America Systemic Infection Therapy Market Share by Application (2015-2020) Table 75. Abbott Laboratories Company Details Table 76. Abbott Laboratories Business Overview Table 77. Abbott Laboratories Product Table 78. Abbott Laboratories Revenue in Systemic Infection Therapy Business (2015-2020) (Million US$) Table 79. Abbott Laboratories Recent Development Table 80. Merck & Co. Company Details Table 81. Merck & Co. Business Overview Table 82. Merck & Co. Product Table 83. Merck & Co. Revenue in Systemic Infection Therapy Business (2015-2020) (Million US$) Table 84. Merck & Co. Recent Development Table 85. Pfizer Company Details Table 86. Pfizer Business Overview Table 87. Pfizer Product Table 88. Pfizer Revenue in Systemic Infection Therapy Business (2015-2020) (Million US$) Table 89. Pfizer Recent Development Table 90. GlaxoSmithKline Company Details Table 91. GlaxoSmithKline Business Overview Table 92. GlaxoSmithKline Product Table 93. GlaxoSmithKline Revenue in Systemic Infection Therapy Business (2015-2020) (Million US$) Table 94. GlaxoSmithKline Recent Development Table 95. Novartis Company Details Table 96. Novartis Business Overview Table 97. Novartis Product Table 98. Novartis Revenue in Systemic Infection Therapy Business (2015-2020) (Million US$) Table 99. Novartis Recent Development Table 100. Johnson & Johnson Company Details Table 101. Johnson & Johnson Business Overview Table 102. Johnson & Johnson Product Table 103. Johnson & Johnson Revenue in Systemic Infection Therapy Business (2015-2020) (Million US$) Table 104. Johnson & Johnson Recent Development Table 105. Sun Pharmaceuticals Company Details Table 106. Sun Pharmaceuticals Business Overview Table 107. Sun Pharmaceuticals Product Table 108. Sun Pharmaceuticals Revenue in Systemic Infection Therapy Business (2015-2020) (Million US$) Table 109. Sun Pharmaceuticals Recent Development Table 110. Roche Business Overview Table 111. Roche Product Table 112. Roche Company Details Table 113. Roche Revenue in Systemic Infection Therapy Business (2015-2020) (Million US$) Table 114. Roche Recent Development Table 115. Astra Zeneca Company Details Table 116. Astra Zeneca Business Overview Table 117. Astra Zeneca Product Table 118. Astra Zeneca Revenue in Systemic Infection Therapy Business (2015-2020) (Million US$) Table 119. Astra Zeneca Recent Development Table 120. Wockhardt Company Details Table 121. Wockhardt Business Overview Table 122. Wockhardt Product Table 123. Wockhardt Revenue in Systemic Infection Therapy Business (2015-2020) (Million US$) Table 124. Wockhardt Recent Development Table 125. Mylan Pharma Company Details Table 126. Mylan Pharma Business Overview Table 127. Mylan Pharma Product Table 128. Mylan Pharma Revenue in Systemic Infection Therapy Business (2015-2020) (Million US$) Table 129. Mylan Pharma Recent Development Table 130. Research Programs/Design for This Report Table 131. Key Data Information from Secondary Sources Table 132. Key Data Information from Primary Sources List of Figures Figure 1. Global Systemic Infection Therapy Market Share by Type: 2020 VS 2026 Figure 2. Oral Features Figure 3. Intravenous Features Figure 4. Topical Features Figure 5. Global Systemic Infection Therapy Market Share by Application: 2020 VS 2026 Figure 6. Hospitals Case Studies Figure 7. Clinics Case Studies Figure 8. Others Case Studies Figure 9. Systemic Infection Therapy Report Years Considered Figure 10. Global Systemic Infection Therapy Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Systemic Infection Therapy Market Share by Regions: 2020 VS 2026 Figure 12. Global Systemic Infection Therapy Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Systemic Infection Therapy Market Share by Players in 2019 Figure 15. Global Top Systemic Infection Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Systemic Infection Therapy as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Systemic Infection Therapy Revenue in 2019 Figure 17. North America Systemic Infection Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Systemic Infection Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 19. China Systemic Infection Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Japan Systemic Infection Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Southeast Asia Systemic Infection Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 22. India Systemic Infection Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Central & South America Systemic Infection Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Abbott Laboratories Revenue Growth Rate in Systemic Infection Therapy Business (2015-2020) Figure 26. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Merck & Co. Revenue Growth Rate in Systemic Infection Therapy Business (2015-2020) Figure 28. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Pfizer Revenue Growth Rate in Systemic Infection Therapy Business (2015-2020) Figure 30. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. GlaxoSmithKline Revenue Growth Rate in Systemic Infection Therapy Business (2015-2020) Figure 32. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Novartis Revenue Growth Rate in Systemic Infection Therapy Business (2015-2020) Figure 34. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Johnson & Johnson Revenue Growth Rate in Systemic Infection Therapy Business (2015-2020) Figure 36. Sun Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Sun Pharmaceuticals Revenue Growth Rate in Systemic Infection Therapy Business (2015-2020) Figure 38. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Roche Revenue Growth Rate in Systemic Infection Therapy Business (2015-2020) Figure 40. Astra Zeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Astra Zeneca Revenue Growth Rate in Systemic Infection Therapy Business (2015-2020) Figure 42. Wockhardt Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Wockhardt Revenue Growth Rate in Systemic Infection Therapy Business (2015-2020) Figure 44. Mylan Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 45. Mylan Pharma Revenue Growth Rate in Systemic Infection Therapy Business (2015-2020) Figure 46. Bottom-up and Top-down Approaches for This Report Figure 47. Data Triangulation Figure 48. Key Executives Interviewed

Abbott Laboratories Merck & Co. Pfizer GlaxoSmithKline Novartis Johnson & Johnson Sun Pharmaceuticals Roche Astra Zeneca Wockhardt Mylan Pharma